David M. Brookline Livingston
#106,421
Most Influential Person Now
David M. Brookline Livingston's AcademicInfluence.com Rankings
David M. Brookline Livingstonbiology Degrees
Biology
#5635
World Rank
#8162
Historical Rank
Cell Biology
#152
World Rank
#159
Historical Rank
Molecular Biology
#517
World Rank
#530
Historical Rank
Genetics
#515
World Rank
#591
Historical Rank

Download Badge
Biology
David M. Brookline Livingston's Degrees
- Masters Biochemistry Stanford University
Why Is David M. Brookline Livingston Influential?
(Suggest an Edit or Addition)David M. Brookline Livingston's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1 (2009) (2300)
- Association of BRCA1 with Rad51 in Mitotic and Meiotic Cells (1997) (1570)
- SV40 large tumor antigen forms a specific complex with the product of the retinoblastoma susceptibility gene (1988) (1478)
- Dicer-deficient mouse embryonic stem cells are defective in differentiation and centromeric silencing. (2005) (1350)
- Activation of Hypoxia-inducible Transcription Factor Depends Primarily upon Redox-sensitive Stabilization of Its α Subunit* (1996) (1203)
- Molecular cloning and functional analysis of the adenovirus E1A-associated 300-kD protein (p300) reveals a protein with properties of a transcriptional adaptor. (1994) (1074)
- Functional interactions of the retinoblastoma protein with mammalian D-type cyclins (1993) (1067)
- Gene Dosage–Dependent Embryonic Development and Proliferation Defects in Mice Lacking the Transcriptional Integrator p300 (1998) (1037)
- Dynamic Changes of BRCA1 Subnuclear Location and Phosphorylation State Are Initiated by DNA Damage (1997) (996)
- Role of T-bet in Commitment of TH1 Cells Before IL-12-Dependent Selection (2001) (965)
- The product of the retinoblastoma susceptibility gene has properties of a cell cycle regulatory element (1989) (902)
- E2F-1 Functions in Mice to Promote Apoptosis and Suppress Proliferation (1996) (858)
- X chromosomal abnormalities in basal-like human breast cancer. (2006) (846)
- Deregulated transcription factor E2F-1 expression leads to S-phase entry and p53-mediated apoptosis. (1994) (846)
- Growth inhibition by TGF-β linked to suppression of retinoblastoma protein phosphorylation (1990) (839)
- Control of BRCA2 cellular and clinical functions by a nuclear partner, PALB2. (2006) (822)
- A Complex with Chromatin Modifiers That Occupies E2F- and Myc-Responsive Genes in G0 Cells (2002) (811)
- Expression cloning of a cDNA encoding a retinoblastoma-binding protein with E2F-like properties (1992) (799)
- An essential role for p300/CBP in the cellular response to hypoxia. (1996) (778)
- Binding and modulation of p53 by p300/CBP coactivators (1997) (767)
- BACH1, a Novel Helicase-like Protein, Interacts Directly with BRCA1 and Contributes to Its DNA Repair Function (2001) (674)
- RAP80 Targets BRCA1 to Specific Ubiquitin Structures at DNA Damage Sites (2007) (673)
- Stable interaction between the products of the BRCA1 and BRCA2 tumor suppressor genes in mitotic and meiotic cells. (1998) (668)
- Aberrant T cell differentiation in the absence of Dicer (2005) (656)
- In search of the tumour-suppressor functions of BRCA1 and BRCA2 (2000) (649)
- Interaction between the retinoblastoma protein and the oncoprotein MDM2 (1995) (632)
- Network modeling links breast cancer susceptibility and centrosome dysfunction. (2007) (628)
- Increased ionizing radiation sensitivity and genomic instability in the absence of histone H2AX (2002) (564)
- A family of transcriptional adaptor proteins targeted by the E1A oncoprotein (1995) (552)
- Functional interactions between BRCA1 and the checkpoint kinase ATR during genotoxic stress. (2000) (550)
- Inhibition of cell proliferation by p107, a relative of the retinoblastoma protein. (1993) (545)
- The transcription factor E2F interacts with the retinoblastoma product and a p107-cyclin A complex in a cell cycle-regulated manner (1992) (539)
- Negative regulation of the growth-promoting transcription factor E2F-1 by a stably bound cyclin A-dependent protein kinase (1994) (515)
- Polyubiquitination of p53 by a Ubiquitin Ligase Activity of p300 (2003) (513)
- TGFβ inhibition of Cdk4 synthesis is linked to cell cycle arrest (1993) (510)
- Identification of cellular proteins that can interact specifically with the T/ElA-binding region of the retinoblastoma gene product (1991) (505)
- Cooperation of Stat2 and p300/CBP in signalling induced by interferon-α (1996) (505)
- Suppression of tumor growth through disruption of hypoxia-inducible transcription (2000) (503)
- SV40 large T antigen binds preferentially to an underphosphorylated member of the retinoblastoma susceptibility gene product family (1989) (492)
- Fanconi anemia is associated with a defect in the BRCA2 partner PALB2 (2007) (486)
- Molecular cloning, chromosomal mapping, and expression of the cDNA for p107, a retinoblastoma gene product-related protein (1991) (484)
- ATM phosphorylation of Nijmegen breakage syndrome protein is required in a DNA damage response (2000) (480)
- BRCA1 is a component of the RNA polymerase II holoenzyme. (1997) (480)
- A recurrent mutation in PALB2 in Finnish cancer families (2007) (475)
- The nuclear hormone receptor coactivator SRC-1 is a specific target of p300. (1996) (470)
- Small molecule blockade of transcriptional coactivation of the hypoxia-inducible factor pathway. (2004) (461)
- p300/MDM2 complexes participate in MDM2-mediated p53 degradation. (1998) (458)
- Localization of human BRCA1 and its loss in high-grade, non-inherited breast carcinomas (1999) (450)
- Gene dose-dependent control of hematopoiesis and hematologic tumor suppression by CBP. (2000) (445)
- Identification of a growth suppression domain within the retinoblastoma gene product. (1992) (442)
- E1A-associated p300 and CREB-associated CBP belong to a conserved family of coactivators (1994) (433)
- Cyclin A-kinase regulation of E2F-1 DNA binding function underlies suppression of an S phase checkpoint (1995) (400)
- Functional role of p35srj, a novel p300/CBP binding protein, during transactivation by HIF-1. (1999) (398)
- Structural basis for recruitment of CBP/p300 by hypoxia-inducible factor-1α (2002) (395)
- The retinoblastoma susceptibility gene product undergoes cell cycle-dependent dephosphorylation and binding to and release from SV40 large T (1990) (384)
- MYC recruits the TIP60 histone acetyltransferase complex to chromatin (2003) (384)
- Genetic analysis of BRCA1 function in a defined tumor cell line. (1999) (383)
- Interaction and functional collaboration of p300/CBP and bHLH proteins in muscle and B-cell differentiation. (1996) (372)
- Involvement of the cell-cycle inhibitor Cip1/WAF1 and the E1A-associated p300 protein in terminal differentiation. (1995) (357)
- E2F-4, a new member of the E2F transcription factor family, interacts with p107. (1994) (350)
- Distinct roles of the co-activators p300 and CBP in retinoic-acid-induced F9-cell differentiation (1998) (334)
- The p400 Complex Is an Essential E1A Transformation Target (2001) (330)
- Multifactorial contributions to an acute DNA damage response by BRCA1/BARD1-containing complexes. (2006) (330)
- Functional interaction between E2F-4 and p130: evidence for distinct mechanisms underlying growth suppression by different retinoblastoma protein family members. (1995) (327)
- BRCA1 Supports XIST RNA Concentration on the Inactive X Chromosome (2002) (325)
- A function for cyclin D1 in DNA repair uncovered by protein interactome analyses in human cancers (2011) (319)
- E2F4 and E2F5 play an essential role in pocket protein-mediated G1 control. (2000) (316)
- Self-excising retroviral vectors encoding the Cre recombinase overcome Cre-mediated cellular toxicity. (2001) (313)
- The T/E1A-binding domain of the retinoblastoma product can interact selectively with a sequence-specific DNA-binding protein (1991) (312)
- BRCA1 Recruitment to Transcriptional Pause Sites Is Required for R-Loop-Driven DNA Damage Repair (2015) (306)
- Relief of YY1 transcriptional repression by adenovirus E1A is mediated by E1A-associated protein p300. (1995) (295)
- The BRCA1/BARD1 Heterodimer Modulates Ran-Dependent Mitotic Spindle Assembly (2006) (286)
- p21 transcription is regulated by differential localization of histone H2A.Z. (2007) (281)
- Specific enzymatic dephosphorylation of the retinoblastoma protein (1993) (274)
- BRCA1 and BRCA2: breast/ovarian cancer susceptibility gene products and participants in DNA double-strand break repair. (2010) (271)
- DICER1 mutations in familial multinodular goiter with and without ovarian Sertoli-Leydig cell tumors. (2011) (260)
- BRCA1, BRCA2, and Rad51 operate in a common DNA damage response pathway. (1999) (258)
- Association of p300 and CBP with simian virus 40 large T antigen (1996) (257)
- The retinoblastoma gene product protects E2F-1 from degradation by the ubiquitin-proteasome pathway. (1996) (255)
- Binding to DNA and the retinoblastoma gene product promoted by complex formation of different E2F family members. (1993) (254)
- The retinoblastoma-susceptibility gene product becomes phosphorylated in multiple stages during cell cycle entry and progression. (1992) (248)
- Location of BRCA1 in Human Breast and Ovarian Cancer Cells (1996) (240)
- Infectious C-type virus isolated from a baboon placenta (1974) (238)
- Polyubiquitinated PCNA recruits the ZRANB3 translocase to maintain genomic integrity after replication stress. (2012) (237)
- An N-Terminal transformation-governing sequence of SV40 large T antigen contributes to the binding of both p110 Rb and a second cellular protein, p120 (1989) (236)
- Interaction of p107 with cyclin A independent of complex formation with viral oncoproteins. (1992) (233)
- The BRCA1-associated protein BACH1 is a DNA helicase targeted by clinically relevant inactivating mutations. (2004) (232)
- Distinct roles for CREB-binding protein and p300 in hematopoietic stem cell self-renewal (2002) (231)
- E2F-Dependent Histone Acetylation and Recruitment of the Tip60 Acetyltransferase Complex to Chromatin in Late G1 (2004) (230)
- Multiple members of the E2F transcription factor family are the products of oncogenes. (1995) (223)
- Structure of the 53BP1 BRCT region bound to p53 and its comparison to the Brca1 BRCT structure. (2002) (223)
- Analysis of PALB2/FANCN-associated breast cancer families (2007) (219)
- RAP80-directed tuning of BRCA1 homologous recombination function at ionizing radiation-induced nuclear foci. (2011) (216)
- Interaction between human cyclin A and adenovirus E1A-associated p107 protein. (1992) (214)
- The subcellular localization of E2F-4 is cell-cycle dependent. (1997) (213)
- An activated ErbB3/NRG1 autocrine loop supports in vivo proliferation in ovarian cancer cells. (2010) (212)
- Definition of the minimal simian virus 40 large T antigen- and adenovirus E1A-binding domain in the retinoblastoma gene product (1990) (208)
- A specific, nonproliferative role for E2F-5 in choroid plexus function revealed by gene targeting. (1998) (204)
- The transcription factor E2F-1 is a downstream target of RB action (1995) (204)
- Unusual proliferation arrest and transcriptional control properties of a newly discovered E2F family member, E2F-6. (1998) (197)
- Immunoaffinity chromatography of proteins. (1974) (190)
- T antigen repression of SV40 early transcription from two promoters (1981) (186)
- p19ARF targets certain E2F species for degradation (2001) (185)
- Expansions of CAG repeat tracts are frequent in a yeast mutant defective in Okazaki fragment maturation. (1998) (181)
- Functional communication between endogenous BRCA1 and its partner, BARD1, during Xenopus laevis development (2001) (154)
- Molecular cloning of cDNA for human von willebrand factor: Authentication by a new method (1985) (152)
- Mapping of SV40 DNA replication origin region binding sites for the SV40 T antigen by protection against exonuclease III digestion (1980) (150)
- SV40 small t antigen enhances the transformation activity of limiting concentrations of SV40 large T antigen (1987) (147)
- An in-tumor genetic screen reveals that the BET bromodomain protein, BRD4, is a potential therapeutic target in ovarian carcinoma (2014) (146)
- The p400 E1A-associated protein is a novel component of the p53 --> p21 senescence pathway. (2005) (145)
- Mechanisms of BRCA1 tumor suppression. (2012) (138)
- Rescue of a telomere length defect of Nijmegen breakage syndrome cells requires NBS and telomerase catalytic subunit (2001) (138)
- Stringent regulation of stably integrated chloramphenicol acetyl transferase genes by E. coli lac repressor in monkey cells (1988) (137)
- Expression and state of phosphorylation of the retinoblastoma susceptibility gene product in cycling and noncycling human hematopoietic cells. (1990) (137)
- Mammalian Cells in Culture Frequently Release Type C Viruses (1973) (136)
- Endogenous type C virus from a cat cell clone with properties distinct from previously described feline type C virus. (1973) (135)
- BRCA1 haploinsufficiency for replication stress suppression in primary cells (2014) (132)
- E2F4 Is Exported from the Nucleus in a CRM1-Dependent Manner (2001) (126)
- Orientation dependence of trinucleotide CAG repeat instability in Saccharomyces cerevisiae (1996) (124)
- Differential effects of cdk2 and cdk3 on the control of pRb and E2F function during G1 exit. (1996) (122)
- Active localization of the retinoblastoma protein in chromatin and its response to S phase DNA damage. (2003) (121)
- Penetrance Analysis of the PALB2 c.1592delT Founder Mutation (2008) (120)
- Regulation of the retinoblastoma protein-related protein p107 by G1 cyclin-associated kinases. (1996) (118)
- Lac repressor can regulate expression from a hybrid SV40 early promoter containing a lac operator in animal cells (1987) (118)
- Radioimmunoassay of mammalian type C viral proteins. I. Species specific reactions of murine and feline viruses. (1972) (117)
- TGF beta inhibition of Cdk4 synthesis is linked to cell cycle arrest. (1993) (115)
- The disappearing Barr body in breast and ovarian cancers (2007) (111)
- BRCA1 is required for postreplication repair after UV-induced DNA damage. (2011) (111)
- PARP1-driven poly-ADP-ribosylation regulates BRCA1 function in homologous recombination-mediated DNA repair. (2014) (109)
- Homeotic transformations of the axial skeleton that accompany a targeted deletion of E2f6 (2002) (108)
- p300 Interacts with the Nuclear Proto-Oncoprotein SYT as Part of the Active Control of Cell Adhesion (2000) (103)
- Control of junB and extracellular matrix protein expression by transforming growth factor-beta 1 is independent of simian virus 40 T antigen-sensitive growth-sensitive growth-inhibitory events (1991) (101)
- Destabilization of CAG trinucleotide repeat tracts by mismatch repair mutations in yeast. (1997) (101)
- Cell cycle analysis of E2F in primary human T cells reveals novel E2F complexes and biochemically distinct forms of free E2F (1993) (101)
- SV40 T antigen interacts with Nbs1 to disrupt DNA replication control. (2004) (100)
- Phosphorylation of the adenovirus E1A‐associated 300 kDa protein in response to retinoic acid and E1A during the differentiation of F9 cells. (1995) (98)
- A recombinant murine retrovirus for simian virus 40 large T cDNA transforms mouse fibroblasts to anchorage-independent growth (1986) (96)
- Centrosomal protein of 192 kDa (Cep192) promotes centrosome-driven spindle assembly by engaging in organelle-specific Aurora A activation (2010) (96)
- Relationship of oligomerization to enzymatic and DNA-binding properties of the SV40 large T antigen (1982) (94)
- Consensus topography in the ATP binding site of the simian virus 40 and polyomavirus large tumor antigens. (1987) (93)
- Identification of regions of the SV40 genome which contain preferred SV40 T antigen-binding sites (1976) (93)
- p300 family members associate with the carboxyl terminus of simian virus 40 large tumor antigen (1997) (93)
- Two familial ALS proteins function in prevention/repair of transcription-associated DNA damage (2016) (92)
- Identification of BRCA1-IRIS, a BRCA1 locus product (2004) (92)
- Trans-activation of RNA polymerase II and III promoters by SV40 small t antigen (1988) (90)
- Relationship between T-antigen and tumor-specific transplantation antigen in simian virus 40-transformed cells (1979) (89)
- Nuclear preparations of SV40-transformed cells contain tumor-specific transplantation antigen activity. (1977) (88)
- Establishment of Patient-Derived Tumor Xenograft Models of Epithelial Ovarian Cancer for Preclinical Evaluation of Novel Therapeutics (2016) (87)
- Systematic screening reveals a role for BRCA1 in the response to transcription-associated DNA damage (2014) (84)
- Further Evidence for BRCA1 Communication with the Inactive X Chromosome (2007) (82)
- Erythropoietin gene regulation depends on heme-dependent oxygen sensing and assembly of interacting transcription factors. (1997) (80)
- Proteomic identification of a direct role for cyclin d1 in DNA damage repair. (2012) (78)
- RNA-dependent DNA polymerase (reverse transcriptase) from avian myeloblastosis virus: a zinc metalloenzyme. (1974) (74)
- The simian virus 40 large T antigen. A lot packed into a little. (1987) (73)
- Protein kinase activity associated with simian virus 40 T antigen. (1979) (72)
- Role of small t antigen in the acute transforming activity of SV40 (1982) (71)
- Small DNA tumor viruses: large contributors to biomedical sciences. (2009) (71)
- RADIOIMMUNOASSAY OF MAMMALIAN TYPE C VIRAL PROTEINS (1972) (69)
- The effect of DNA replication mutations on CAG tract stability in yeast. (1999) (68)
- Biosynthesis of the subunits of factor VIIIR by bovine aortic endothelial cells. (1983) (67)
- Relationship between RNA-directed DNA polymerase (reverse transcriptase) from human acute leukemic blood cells and primate type-C viruses. (1974) (66)
- Cystine requirement of continuous human lymphoid cell lines of normal and leukemic origin. (1977) (63)
- The impact of lagging strand replication mutations on the stability of CAG repeat tracts in yeast. (2000) (62)
- Molecular cloning and chromosomal localization of the human CITED2 gene encoding p35srj/Mrg1. (1999) (60)
- p400 Is Required for E1A to Promote Apoptosis* (2005) (60)
- Deoxyribonucleic acid sequence organization of a yeast plasmid (1977) (60)
- X chromosome inactivation in the absence of Dicer (2009) (59)
- Cloning, sequencing, and expression of the Pseudomonas putida protocatechuate 3,4-dioxygenase genes (1993) (59)
- PP2A-mediated regulation of Ras signaling in G2 is essential for stable quiescence and normal G1 length. (2014) (55)
- Deoxyribonucleic acid polymerase III of Escherichia coli. Characterization of associated exonuclease activities. (1975) (55)
- Intracellular neutralization of SV40 tumor antigens following microinjection of specific antibody (1980) (54)
- Palb2 synergizes with Trp53 to suppress mammary tumor formation in a model of inherited breast cancer (2013) (53)
- Independence of R/M/N focus formation and the presence of intact BRCA1. (2000) (52)
- Inadequate DNA Damage Repair Promotes Mammary Transdifferentiation, Leading to BRCA1 Breast Cancer (2019) (51)
- BRCA 1 Recruitment to Transcriptional Pause Sites Is Required for R-Loop-Driven DNA Damage Repair (51)
- BRCA1/FANCD2/BRG1-Driven DNA Repair Stabilizes the Differentiation State of Human Mammary Epithelial Cells. (2016) (49)
- The T/t common region of simian virus 40 large T antigen contains a distinct transformation-governing sequence (1991) (48)
- Deoxyribonucleic acid polymerase III of Escherichia coli. Purification and properties. (1975) (47)
- MOLECULAR CLONING OF THE HUMAN GENE FOR VON WILLEBRAND FACTOR AND IDENTIFICATION OF THE TRANSCRIPTION INITIATION SITE (1987) (47)
- Characterization of a unique cell line (LAZ 221) from human acute lymphocytic ("null" cell) leukemia. (1978) (47)
- The adenovirus E1A-associated 300-kD protein exhibits properties of a transcriptional coactivator and belongs to an evolutionarily conserved family. (1994) (47)
- Regulation of endogenous E2F1 stability by the retinoblastoma family proteins. (1999) (45)
- Purification and functional properties of simian virus 40 large and small T antigens overproduced in insect cells (1988) (45)
- Thermolabile T (tumor) antigen from cells transformed by a temperature-sensitive mutant of simian virus 40. (1975) (44)
- Association of BRCA1 with the inactive X chromosome and XIST RNA. (2004) (44)
- Synthesis of simian virus 40 t antigen in Escherichia coli. (1979) (43)
- Abnormalities of tryptophan metabolism and plasma pyridoxal phosphate in Hodgkin's disease. (1970) (43)
- Infectious type C viruses released by normal cat embryo cells. (1973) (43)
- BRCA1 Pathway Function in Basal-Like Breast Cancer Cells (2014) (42)
- Biological and biochemical studies of cells transformed by simian virus 40 temperature-sensitive gene A mutants and A mutant revertants (1977) (42)
- Simian virus 40 small tumor antigen and an amino-terminal domain of large tumor antigen share a common transforming function. (1990) (42)
- Subunit composition of oligomeric human von Willebrand factor. (1983) (41)
- Purification of biologically active simian virus 40 small tumor antigen. (1983) (41)
- Crebbp haploinsufficiency in mice alters the bone marrow microenvironment, leading to loss of stem cells and excessive myelopoiesis. (2011) (41)
- Endogenous E2F-1 promotes timely G0 exit of resting mouse embryo fibroblasts. (1998) (40)
- Specific in vitro adenylylation of the simian virus 40 large tumor antigen. (1984) (39)
- Novel consensus DNA‐binding sequence for BRCA1 protein complexes (2003) (39)
- Zinc reverse transcriptases from mammalian RNA type C viruses. (1975) (37)
- Supporting Online Material for Rap 80 Targets BRCA 1 to Specific Ubiquitin Structures at DNA Damage Sites (2007) (36)
- The t-unique coding domain is important to the transformation maintenance function of the simian virus 40 small t antigen (1986) (36)
- Reverse transcriptase from avian myeloblastosis virus: a zinc metalloenzyme. (1974) (36)
- Measurements of the molecular size of the simian virus 40 large T antigen (1978) (35)
- SMCX and components of the TIP60 complex contribute to E2 regulation of the HPV E6/E7 promoter. (2014) (34)
- BRCA1 binds TERRA RNA and suppresses R-Loop-based telomeric DNA damage (2021) (34)
- Localization of the simian virus 40 small t antigen in the nucleus and cytoplasm of monkey and mouse cells (1984) (33)
- Superinduction of Endogenous Type C Virus by 5-Bromodeoxyuridine from Transformed Mouse Clones (1973) (32)
- Phenotypic complementation of the SV40 tsA mutant defect in viral DNA synthesis following microinjection of SV40 T antigen (1978) (32)
- Partial purification and characterization of the SV40 T antigen. (1974) (32)
- Chemical modification of carboxypeptidase A crystals. Azo coupling with tyrosine-248. (1972) (31)
- Transrepression of RNA polymerase II promoters by the simian virus 40 small t antigen (1994) (31)
- Interaction of Simian Virus 40 chromatin with Simian Virus 40 T-antigen (1977) (30)
- Interaction of partially purified simian virus 40 T antigen with circular viral DNA molecules. (1975) (29)
- Expression of abnormal von Willebrand factor by endothelial cells from a patient with type IIA von Willebrand disease. (1987) (29)
- Binding of simian virus 40 large T antigen from virus-infected monkey cells to wild-type and mutant viral replication origins. (1983) (28)
- An Activated ErbB 3 / NRG 1 Autocrine Loop Supports In Vivo Proliferation in Ovarian Cancer Cells (27)
- Accumulation of cystine auxotrophic thymocytes accompanying type C viral leukemogenesis in the mouse (1976) (27)
- Tumor Suppression by a Severely Truncated Species of Retinoblastoma Protein (2002) (26)
- Toward mechanism-based cancer care. (2001) (25)
- Affinity chromatography of RNA-dependent DNA polymerase from RNA tumor viruses on a solid phase immunoadsorbent. (1972) (25)
- Abnormalities of the inactive X chromosome are a common feature of BRCA1 mutant and sporadic basal-like breast cancer. (2005) (24)
- Affinity chromatography of avian type C viral reverse transcriptase: studies with Rous sarcoma virus transformed rat cells. (1972) (24)
- Binding of an analog of the simian virus 40 T antigen to wild-type and mutant viral replication origins. (1982) (23)
- Anergy and tryptophan metabolism in Hodgkin's disease. (1971) (23)
- Two different E2F6 proteins generated by alternative splicing and internal translation initiation. (2002) (22)
- RB associates with an E2F-like, sequence-specific DNA-binding protein. (1991) (21)
- Identification and initial characterization of a new low-molecular-weight virus-encoded T antigen in a line of simian virus 40-transformed cells (1980) (21)
- Chemically facilitated microinjection of proteins into intact monolayers of tissue culture cells (1977) (19)
- Identification of infectious virions which are vesicular stomatitis virus pseudotypes of murine type C virus. (1976) (19)
- BRCA1 and RNAi factors promote repair mediated by small RNAs and PALB2–RAD52 (2021) (19)
- Physiological modulation of endogenous BRCA1 p220 abundance suppresses DNA damage during the cell cycle (2013) (19)
- Purification and subunit structure of mouse liver cystathionase. (1978) (18)
- Spectro-chemical probes for protein conformation and function. (1972) (18)
- BRCA1-IRIS promotes human tumor progression through PTEN blockade and HIF-1α activation (2018) (18)
- Cancer: Crossing over to drug resistance (2008) (18)
- Independence of R/M/N Focus Formation and the Presence of Intact BRCA1 (2000) (17)
- SV40 T antigen: partial purification and properties. (1975) (17)
- Cellular proteins which can specifically associate with simian virus 40 small t antigen (1986) (17)
- Characterization of a new murine cellular DNA polymerase. (1974) (16)
- Polyoma small T antigen triggers cell death via mitotic catastrophe (2014) (16)
- Papillomavirus E7 Oncoproteins Share Functions with Polyomavirus Small T Antigens (2014) (16)
- EMSY, a BRCA-2 partner in crime (2004) (16)
- Enzymatic activities associated with the SV40 large T antigen. (1980) (16)
- Mechanisms of BRCA 1 Tumor Suppression (2012) (16)
- Structural and functional contributions to the G1 blocking action of the retinoblastoma protein. (the 1992 Gordon Hamilton Fairley Memorial Lecture). (1993) (15)
- Meiotic alterations in CAG repeat tracts. (2001) (15)
- PenetranceAnalysis of the PALB 2 c . 1592 delT Founder Mutation (2008) (13)
- Purification of simian virus 40 tumor antigen from a line of simian virus 40-transformed human cells. (1977) (13)
- Conformational and activity changes on subtilisin cleavage of carboxypeptidase A. (1971) (12)
- Complicated Supercomplexes (2009) (12)
- Cysteine auxotrophy of human leukemic lymphoblasts is associated with decreased amounts of intracellular cystathionase protein. (1981) (12)
- Cancer: Chromosome defects in the colon (2001) (12)
- Isolation of a specialized transducing bacteriophage lambda carrying the polC locus of Escherichia coli. (1974) (11)
- Control of JunB and Extracellular Matrix Protein Expression by Transforming Growth Factor-1l Is Independent of Simian Virus 40 T Antigen-Sensitive Growth-Inhibitory Events (10)
- Septic complications in the trauma patient (1999) (9)
- Interactions of the Nijmegen breakage syndrome protein with ATM and BRCA1. (2000) (9)
- Effect of a stem-loop structure within the SV40 replication origin upon SV40 T antigen binding to origin region sequences (1983) (8)
- Localization of human CREB-binding protein gene (CREBBP) to 16p13.2-p13.3 by fluorescence in situ hybridization. (1995) (8)
- Rapid and sensitive quantitative immunoassay for the large simian virus 40 T antigen (1981) (8)
- Twenty-fourth annual Pezcoller symposium: Molecular basis for resistance to targeted agents. (2013) (7)
- RAP80 and BRCA1 PARsylation protect chromosome integrity by preventing retention of BRCA1-B/C complexes in DNA repair foci (2020) (7)
- Cysteine auxotrophy of human leukemic lymphoblasts is associated with decreased amounts of intracellular cystathionase messenger ribonucleic acid. (1981) (6)
- Opening a Door to PARP Inhibitor-Induced Lethality in HR-Proficient Human Tumor Cells. (2020) (5)
- Immunologic analyses of mouse cystathionase in normal and leukemic cells. (1978) (5)
- Lack of SV40 DNA in tumors from scientists working with SV40 virus. (1991) (5)
- Reply to “Promoter usage of BRCA1-IRIS” (2005) (3)
- Twenty-second annual Pezcoller Symposium: RNA biology and cancer. (2010) (3)
- BRCA1/Trp53 heterozygosity and replication stress drive esophageal cancer development in a mouse model (2021) (3)
- Formation of a cruciform structure at the simian virus 40 replication origin abolishes T-antigen binding to the origin in vitro (1985) (3)
- Murine sarcoma virus-transformed nonproducer rat cell lines resistant to type C-virus infection. (1973) (3)
- Book ReviewCancer: A comprehensive treatise. Vol. 2. Etiology: Viral carcinogenesis: (1976) (2)
- DNA Polymerases of Escherichia coli (1973) (2)
- Genetics is coming to oncology. (1997) (2)
- Protein kinase activity associated with simian virus 40 T antigen ( immunoprecipitation assay / casein phosphorylation / tsA mutant protein ) (1)
- Cancer genes: functional aspects. Meeting report. (1996) (1)
- Eleventh annual Pezcoller Symposium: molecular horizons in cancer therapeutics. (2000) (1)
- Twenty-third annual Pezcoller Symposium: engineering influences in cancer research. (2012) (1)
- Twenty-first annual Pezcoller Symposium: Unconventional Therapeutic Targets in Cancer. (2010) (1)
- George Khoury (1943–1987) (1987) (1)
- A High Mobility Group Protein Binds to Long CAG Repeat Tracts and Establishes Their Chromatin Organization (2006) (1)
- E2F-1 Degradation by the Ubiquitin-Proteasome Pathway (1997) (1)
- Studies on the type C viral replication defect in MSV-transformed rat nonproducer variant clones. (1974) (1)
- Detection of type C viruses in normal and transformed cells. (1973) (1)
- Number : DAMD 17-021-0360 TITLE : Functional Study of the Human BRCA 2 Tumor Suppressor (0)
- NMR Structures of the HIF-1alpha CTAD/p300 CH1 Complex (2002) (0)
- A Model System. (Book Reviews: Growth and Differentiation in Physarum polycephalum) (1981) (0)
- A method for detection of ovarian cancer (2006) (0)
- Analysis of BRCA1-related functional associations in sporadic triple negative breast cancer: A network-based approach. (2016) (0)
- p 21 senescence pathway → The p 400 E 1 A-associated protein is a novel component of the p 53 Material Supplemental (2004) (0)
- Acute Lymphocytic ( ' ' Null ' ' Cell ) Leukemia Characterization of a Unique Cell Line ( LAZ 221 ) from Human Updated (2006) (0)
- 26th Pezcoller symposium: cancers driven by hormones. (2015) (0)
- Light emitting fusion proteins as well as diagnostic and therapeutic procedures for (2002) (0)
- Abstract IA3: In tumor screening for novel targets in papillary serous ovarian cancer (2013) (0)
- 336 Intricacies of BRCA1 genome integrity control and cancer suppression functions (2010) (0)
- The BRCA1 isoform, BRCA1-IRIS, operates independently of the full-length BRCA1 in the Fanconi anemia pathway (2022) (0)
- Tumor virology updated. (1981) (0)
- To the editor: [1] (1991) (0)
- 1H, 13C, and 15N Chemical Shift Assignments for the HIF-1alpha CTAD/p300 CH1 Complex (2003) (0)
- Understanding Endogenous c-Myc Function in Human Breast Cancer Development (2003) (0)
- 03:09 PM Abstract No. 113 Lobar Yttrium-90 transarterial radioembolization equal or greater than 150Gy MIRD: an analysis of hepatic biochemical safety as a function of treated liver volume and administered dose (2019) (0)
- 67: Unexpected cancer-related properties of BRCA1 (2014) (0)
- Microenvironment and Immunology Transcription Factor NFATc 2 Controls the Emergence of Colon Cancer Associated with IL-6 – Dependent Colitis (2012) (0)
- Cyclin A-Kinase Binding to and Regulation of the Function of a Growth-Promoting Transcription Factor (1996) (0)
- ABNORMAL EXPRESSION OF VON WILLEBRAND FACTOR BY ENDOTHELIAL CELLS FROM A PATIENT WITH TYPE IIA VON WILLEBRAND’ S DISEASE (1987) (0)
- Obituary (1988) (0)
- PROTEINS III. DETECTION OF VIRAL ANTIGEN IN NORMAL MURINE CELLS AND TISSUES (1973) (0)
- BRCA1 and RNAi factors promote small RNA- and PalB2/Rad52-mediated repair (2021) (0)
- Crystal Structure of the 53bp1 BRCT Region Complexed to Tumor Suppressor P53 (2002) (0)
- A Family of High Molecular Weight Proteins Active in Differentiation and Growth Control (1995) (0)
- Molecular cloning of the human gene for von Willebrand factor and identification of the transcription initiation site ( human genomic clones / promoter / cross-species homology ) (0)
- Identification de composes qui modifient les reponses transcriptionnelles a l'hypoxie (2000) (0)
- Cell Cycle Analysis of the BRCA1 Gene Product (1999) (0)
- Pyridoxine and anergy in Hodgkin's disease. (1970) (0)
- Identification of materials, the transcriptional respond to hypoxia modify (2000) (0)
- Overexpression of BRCA1-IRIS protein in familial ovarian cancers with no BRCA1 or BRCA2 germline mutation (2016) (0)
- Proteomic Identi fi cation of a Direct Role for Cyclin D 1 in DNA Damage Repair (2012) (0)
- 2 Effect of ecto-5 ’-nucleotidase inhibition on the invasive phenotype of the murine B 16 F 10 melanoma cell line (2011) (0)
- Foreword (1998) (0)
- Subject Index, Vol. 1, 1973 (1973) (0)
- Cell cycle regulated E2F1 degradation by the ubiquitin-proteasome pathway (1996) (0)
- Contents, Vol. 1, 1973 (1973) (0)
- Mechanisms that could increase cancer vulnerability in COVID-19 mRNA vaccine recipients (0)
- Cell Cycle of the BRCA1 Gene Product (1998) (0)
- Crystal Structure of rat Brca1 tandem-BRCT region (2002) (0)
- Tumor Virology Updated: Molecular Biology of Tumor Viruses . Second edition. Part 2, DNA Tumor Viruses. John Tooze, Ed. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y., 1980. xii, 958 pp., illus. $55. (1981) (0)
- Cellular Proteins WhichCanSpecifically Associate withSimian Virus40Small tAntigen (1986) (0)
- Identifying compounds that modify transcriptional responses to hypoxia. (2000) (0)
- modify responses to hypoxia (2000) (0)
- Book-Review - the Master of Light (1980) (0)
- Functional Study of the Human BRCA2 Tumor Suppressor (2005) (0)
- Twenty-fifth annual Pezcoller Symposium: Metabolism and tumorigenesis. (2013) (0)
- Abstract S5-05: Defective stalled replication fork repair and predisposition to hereditary breast cancer (2015) (0)
- Pezcoller Symposium : Cancers Driven by Hormones (2015) (0)
- BRCA 1 / BARD 1-containing complexes Multifactorial contributions to an acute DNA damage response (2005) (0)
- Detection of ErbB dimers in cell lines and breast cancer tissue using DNA programmed chemistry (2008) (0)
- Promoter usage of BRCA1-IRIS. (2005) (0)
- The connection between research and practice Basic Research and Clinical Medicine. Edited by S. P. Bralow. Washington, D. C.: Hemisphere Publishing Corporation. (1982). 280 pp. $33.50 (1982) (0)
- LARGE SV 40 T ANTIGEN MOLECULAR WEIGHT 219 problematic if the genuine size of the large (0)
This paper list is powered by the following services:
What Schools Are Affiliated With David M. Brookline Livingston?
David M. Brookline Livingston is affiliated with the following schools: